Evidence map›Paper›PMID 33706806›Full record

ReviewJournal of biological engineering2021

Biotechnological Activities and Applications of Bacterial Pigments Violacein and Prodigiosin.

Seong Yeol Choi, Sungbin Lim, Kyoung-Hye Yoon, Jin I Lee, Robert J Mitchell

Abstract readReview
In one paragraph

Review in Journal of biological engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Metacycloprodigiosin produced by a high-yieldOrganic & biomolecular chemistry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Promising Prodiginins Biological Activities.Chemistry & biodiversity · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Stability of a MutualisticEngineering in life sciences · 2024
    Article
  17. Pigments from pathogenic bacteria: a comprehensive update on recent advances.World journal of microbiology & biotechnology · 2024
    Review
  18. Review
  19. Genomic Insights intoJournal of microbiology and biotechnology · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Seong Yeol Choi *School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, South Korea.
Sungbin Lim *School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, South Korea.
Kyoung-Hye YoonDepartment of Physiology, Mitohormesis Research Center, Yonsei University Wonju College of Medicine, Wonju, Gangwon-do, South Korea. kyounghyeyoon@yonsei.ac.kr.
Jin I LeeDivision of Biological Science and Technology, College of Science and Technology, Yonsei University, Mirae Campus, Wonju, Gangwon-do, South Korea. jinillee@yonsei.ac.kr.
Robert J MitchellSchool of Life Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, South Korea. esgott@unist.ac.kr.ORCID http://orcid.org/0000-0002-9608-5381

Funding

National Research Foundation of Korea 2019R1C1C1008708National Research Foundation of Korea 2020R1A2C2012158National Research Foundation of Korea 2020R1F1A1073848
6 · The paper itself

Abstract

In this review, we discuss violacein and prodigiosin, two chromogenic bacterial secondary metabolites that have diverse biological activities. Although both compounds were "discovered" more than seven decades ago, interest into their biological applications has grown in the last two decades, particularly driven by their antimicrobial and anticancer properties. These topics will be discussed in the first half of this review. The latter half delves into the current efforts of groups to produce these two compounds. This includes in both their native bacterial hosts and heterogeneously in other bacterial hosts, including discussing some of the caveats related to the yields reported in the literature, and some of the synthetic biology techniques employed in this pursuit.

Indexed as

AntibacterialAnticancerProdigiosinProductionSecondary MetaboliteSynthetic BiologyViolacein

Identifiers

PMID33706806
PMCPMC7948353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.